| RESEARCH ARTICLE |
|
| Year : 2008 | Volume
: 29
| Issue : 3 | Page : 128-132 |
|
|
Effect of Shireeshadi Ghanavati in the Management of Tamaka Shwasa
Shweta Agarwa1, MS Baghel2
1 M.D. (Ayu.), Department of Kayachikitsa, IPGT & RA, Gujarat Ayurved University, Jamnagar, India
2 Director, IPGT & RA, Gujarat Ayurved University, Jamnagar, India
Correspondence Address:
Shweta Agarwa
M.D. (Ayu.), Department of Kayachikitsa, IPGT & RA, Gujarat Ayurved University, Jamnagar
India
 Source of Support: None, Conflict of Interest: None  | Check |
|
|
|
Considering the high prevalence of the disease and the need to look for alternative medicine, a randomized open clinical trial on 29 subjects of Tamaka Shwasa (Bronchial Asthma), screened on the basis of clinical findings were allocated to two groups. Group A having 15 cases received the trial drug Shireeshadi Ghanavati (SGV) and 14 cases in Group B received Shwasa Kuthar Rasa (SKR) as a control drug. In SGV group, 13.33% of patients were observed with complete remission and 40% patients got marked improvement, 20% each were observed as improved as well as unchanged. The response was encouraging and left the scope for further study. |
|
|
|
| [PDF Not available]* |
|
 |
|
